Home › Companies › Tera Science

Tera Science

테라사이언스 · 073640 · KOSDAQ
Filings, last 12 months
104
Supply contracts
0
Insider reports
0
Share & bond issues
1

At a glance

Tera Science filed 104 disclosures in the last 12 months, including 1 issuance and 1 m&a. The most recent key filing was on Jun 18.

Revenue for 2025 was ₩14.1B, down 18.2% on 2024. It made an operating loss of ₩10.1B. Debt was 97% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩7.6B and operating loss of ₩3.9B.

The 2025 annual report lists 90 employees with an average tenure of 3.1 years and average pay of ₩47.9M, #1542 of 1,829 listed companies by average pay. Its 6 directors and auditors were paid ₩112.8M each on average. It paid no cash dividend for 2025. 위플러스 투자조합 and related parties held 10.14% at year end.

From the 2025 annual report

Employees
90
Average pay
₩47.9M
Average tenure
3.1 yrs
Avg. director pay
₩112.8M

Staff: 90 (47 men, 43 women), of whom 20 on fixed-term contracts. Total pay for the year: ₩4.3B. Directors and auditors: 6, paid ₩677M in total.

No cash dividend was paid for 2025.

Largest shareholder

위플러스 투자조합 holds 10.14%; with 0 related parties the group holds 10.14% of common shares at year end (from 0.00% at the start of the year).

Auditor: 대주회계법인 · opinion: Disclaimer of opinion. The report includes an emphasis of matter.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

2023
Revenue ₩23.1B
Op. profit -₩4.5B
Debt/equity 52%
2024
Revenue ₩17.3B
Op. profit -₩9.4B
Debt/equity 51%
2025
Revenue ₩14.1B
Op. profit -₩10.1B
Debt/equity 97%
2026 H1
Revenue ₩7.6B
Op. profit -₩3.9B
Debt/equity 111%
RevenueOperating profitOperating lossConsolidated where available · from periodic reports

Key filings

10/29IssuanceAmendedRights offering
9/30IssuanceAmendedRights offering
8/31M&AAmendedTangible asset deal
8/27IssuanceAmendedRights offering
7/30IssuanceAmendedRights offering
7/2IssuanceAmendedRights offering
6/18IssuanceRights offering
6/18IssuanceAmendedRights offering
6/12IssuanceAmendedRights offering
5/29IssuanceAmendedRights offering
5/20IssuanceAmendedRights offering
4/21IssuanceAmendedRights offering
4/9IssuanceAmendedRights offering
4/9M&AAmendedTangible asset deal
3/20ExchangeExchange
3/12IssuanceAmendedRights offering
2/6IssuanceAmendedRights offering
1/12IssuanceAmendedRights offering
12/10IssuanceAmendedRights offering
11/28ExchangeTrading halt
11/28ExchangeExchange
11/27ExchangeTrading halt
11/17IssuanceAmendedRights offering

Other filings

Links open the original filing on DART, in Korean.